PROGRAMME EHMSG Workshop
Friday, September 8, 2023
08.00 – 10.00 hrs Session 1: What’s happening in H.pylori and gut microbiota
08.00 – 08.20
01.01. Microbiome predicting the development of diseases in the population
Rinse Weersma, Groningen, The Netherlands
08.20 – 08.40
01.02. Helicobacter pylori: a stealth assassin
Richard Peek, Nashville, TN, USA
08.40 – 09.00
01.03. Breakthroughs and bottlenecks in microbiome research
Marie Joossens, Ghent, Belgium
09.00 – 09.20
01.04. Microbiota testing
Gianluca Ianiro, Rome, Italy
09.20 – 09.40
01.05. Impact of H. pylori eradication on gut microbiota
Jyhming Liou, Taipei, Taiwan
09.40 – 10.00
01.06. Gastric cancer and metabolomic profile
Jun-Young Seo, Seoul, Korea
10.00 - 10.30 hrs Coffee Break
10.30 – 12.30 hrs Session 2: News on gastritis (Parallel Session)
10.30 – 10.50
02.01. The evolution in gastritis classification - the REGAIN initiative
Massimo Rugge, Padua, Italy
10.50 – 11.10
02.02. H. pylori and its crosstalk to other gastric bacteria
Christian Schulz, Munich, Germany
11.10 – 11.30
02.03. The role of H. pylori and other microorganisms in autoimmune gastritis
Bruno Annibale, Roma, Italy
11.30 – 11.50
02.04. New developments and directions in H. pylori prevention and progression of gastritis
Thomas Boren, Umea, Sweden
11.50 – 12.02
02.05. Talk from Submitted Abstracts
12.02 – 12.14
02.06. Talk from Submitted Abstracts
12.14 – 12.26
02.07. Talk from Submitted Abstracts
10.30 – 12.30 hrs Session 3: Microbiome mechanisms of action (Parallel Session)
10.30 – 10.50
03.01. Oncobiome
Jorge Galena Nino, Seattle, WA, USA
10.50 – 11.10
03.02. Using tools to make predictions
Tove Fall, Uppsala, Sweden
11.10 – 11.30
03.03. Microbial manipulation using model systems
Georgina Hold, Sydney, Australia
11.30 – 11.50
03.04. Dietary manipulation and its influence on microbial communities
Jeongseon Kim, Goyang-si, Korea
11.50 – 12.02
03.05. Talk from Submitted Abstracts
12.02 – 12.14
03.06. Talk from Submitted Abstracts
12.14 – 12.26
03.07. Talk from Submitted Abstracts
12.30 – 14.00 hrs Lunch Break & Poster Viewing
14.00 - 16.00 Session 4: Helicobacter pylori Genome Project (HpGP) (Parallel Session)
14.00 – 14.10
04.01. Overview of HpGP
Constanza Camargo, Rockville, MD, USA
14.10 – 14.30
04.02. New insights into Helicobacter pylori population structure from the HpGP
Kaisa Thorell, Gothenburg, Sweden
14.30 – 14.50
04.03. Disclosing prophage genomics in the HpGP
Filipa Vale, Lisbon, Portugal
14.50 – 15.10
04.04. Identification and characterization of plasmids in Helicobacter pylori
Roberto Torres, Shanghai, China
15.10 – 15.30
04.05. The DNA methylases found in Helicobacter pylori strains
Richard Roberts, Ipswich, MA, USA
15.30 – 15.45
Q&A – participation of all HpGP investigators
15.45 – 16.00
04.06. Talk from Submitted Abstracts
14.00 - 16.00 hrs Session 5: Microbiota modulation for a healthy life (Parallel Session)
14.00 – 14.20
05.01. Diet and lifestyle
Francesco Franceschi, Rome, Italy
14.20 – 14.40
05.02. Pre- and Probiotics
Francesca Ponziani, Rome, Italy
14.40 – 15.00
05.03. Postbiotics
Tom Van de Wiele, Ghent, Belgium
15.00 – 15.20
05.04. Antibiotics
Antonio Gasbarrini, Rome, Italy
15.20 – 15.32
05.05. Talk from Submitted Abstracts
15.32 – 15.44
05.06. Talk from Submitted Abstracts
15.44 – 15.56
05.07. Talk from Submitted Abstracts
16.00 - 16.30 hrs Coffee Break
16.30 - 18.30 hrs Session 6: Gastric Carcinogenesis (Parallel Session)
16.30 – 16.50
06.01. A single H. pylori SNP controlling gastric cancer development
Steffen Backert, Erlangen, Germany
16.50 – 17.10
06.02. Cellular differentiation and neoplastic transformation of the gastric mucosa
Michael Sigal, Berlin, Germany
17.10 – 17.30
06.03. Gastric Cancer stem cells and metastasis
Christine Varon, Bordeaux, France
17.30 – 17.50
06.04. Impact of H. pylori infection on cancer immunotherapies
Dominique Velin, Lausanne, Switzerland
17.50 – 18.02
06.05. Talk from Submitted Abstracts
18.02 – 18.14
06.06. Talk from Submitted Abstracts
18.14 – 18.26
06.07. Talk from Submitted Abstracts
16.30 - 18.30 hrs Session 7: Microbiota modulation by FMT (Parallel Session)
16.30 – 16.50
07.01. FMT beyond Clostridioides difficile
Josbert Keller, Leiden, The Netherlands
16.50 – 17.10
07.02. FMT preparations: modification, lyophylization, or spores
Christian Hvas, Aarhus, Denmark
17.10 – 17.20
07.03. Safety of FMT and prospective registries
Maria Vehreschild, Frankfurt, Germany
17.20 – 17.35
07.04. Gastric microbiome modulation via FMT and immunity
Juan Du, Solna, Sweden
17.35 – 17.50
07.05. Factors underlying FMT efficacy
Harry Sokol, Paris, France
17.50 – 18.02
07.06. Talk from Submitted Abstracts
18.02 – 18.14
07.07. Talk from Submitted Abstracts
18.14 – 18.26
07.08. Talk from Submitted Abstracts
20.00 hrs Networking Dinner
Saturday, September 9, 2023
08.30 – 09.00 hrs Session 8: Memorial Talks
08.30 – 08.45
08.01. In Memoriam Michel Deltenre
Rufin Ntounda, Brussels, Belgium
08.45 – 09.00
08.02. In Memoriam Jose Pajares
Javier Gisbert, Madrid, Spain
09.00 - 11.00 hrs Session 9: H pylori management (Parallel Session)
09.00 – 09.20
09.01. The search for new drug targets and therapies
Sinead Smith, Dublin, Ireland
09.20 – 09.40
09.02. Lessons from the first 10 years from the European registry
Olga Nyssen, Madrid, Spain
09.40 – 10.00
09.03. Integration of antimicrobial susceptibility testing
David Graham, Houston, TX, USA
10.00 – 10.20
09.04. Personalised eradication treatment in Korea
Seong Woo Jeon, Daegu, Korea
10.20 – 10.32
09.05. Talk from Submitted Abstracts
10.32 – 10.44
09.06. Talk from Submitted Abstracts
10.44 – 10.56
09.07. Talk from Submitted Abstracts
09.00 - 11.00 hrs Session 10: Diseases & Microbiota (Parallel Session)
09.00 – 09.20
10.01. Gastric cancer and microbiota
Emilie Bessède, Bordeaux, France
09.20 – 09.40
10.02. Autism and Microbiota
Zain Kassam, Cambridge, MA, USA
09.40 – 10.00
10.03. Mycobiota in cancer
Alexander Link, Magdeburg, Germany
10.00 – 10.20
10.04. Leaky gut and circulating microbiome
Juozas Kupcinskas, Kaunas, Lithuania
10.20 – 10.32
10.05. Talk from Submitted Abstracts
10.32 – 10.44
10.06. Talk from Submitted Abstracts
10.44 – 10.56
10.07. Talk from Submitted Abstracts
11.00 - 11.30 hrs Coffee Break
11.30 – 12.30 hrs Session 11 - Industry-Sponsored Satellite Symposium
More information will be available soon
12.30 – 14.30 hrs Lunch Break & Poster Viewing
14.30 - 15.30 hrs Session 12: Debates – Search for the truth
14.30 – 14.50
H.pylori is a protective factor for oesophageal disease
14.30 – 14.40 12.01. Yes: Theodore Rokkas, Athens, Greece
14.40 – 14.50 12.02. No: Jan Bornschein, Oxford, United Kingdom
14.50 – 15.10
Acid suppression can cause gastric cancer
14.50 – 15.00 12.03. Yes: Chan Hyuk Park, Seoul, Korea
15.00 – 15.10 12.04. No: Peter Malfertheiner, Munich, Germany
15.10 – 15.30
Microbiota in IBS: Chicken or egg?
15.10 – 15.20 12.05. Sébastien Kindt, Brussels, Belgium
15.20 – 15.30 12.06. Heiko de Schepper, Antwerp, Belgium
15.30 - 17.20 hrs Session 13: Updates in Helicobacter & Microbiota
15.30 – 15.50
13.01. Carcinogenesis and Lymphomagenesis - basic aspects
Mario D’Elios, Siena, Italy
15.50 – 16.10
13.02. Carcinogenesis and Lymphomagenesis - clinical aspects
Tamara Matysiak, Nantes, France
16.10 – 16.30
13.03. Gut microbiota and functional bowel disease
Jan Tack, Leuven, Belgium
16.30 – 16.50
13.04. Microbiota in reproductive health
Sarah Lebeer, Antwerp, Belgium
16.50 – 17.20
Clinical applications of gut microbiota (Tandem Talk)
16.50 – 17.05 13.05. Francis Chan, Hong Kong, China
17.05 – 17.20 13.06. Siew Ng, Hong Kong, China
17.20 - 18.00 hrs Session 14: Closing Session
17.20 – 17.30
14.01. Awarding of the Marshall and Warren Medal 2023 to Youri Glupczynski, Brussels, Belgium
17.30 – 17.40
14.02. Presentation of the Journal & Awarding of the best paper
F. Franceschi, Rome, Italy
17.40 – 17.50
14.03. Awarding of the EHMSG Oral and Poster Awards
17.50 – 18.00
14.04. Presentation of the next meeting in Porto, Portugal
José Machado, Porto, Portugal
Closing Remarks